Skip to main content

Table 3 The fractions of various subsets of cells among the CD4 + or CD8 + T cells, or CD19 + B cells

From: Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells

 

Controls (n = 18)

MS

  

Overall (n = 30)

RRMS (n = 17)

SPMS (n = 6)

PPMS (n = 7)

CD21+ in CD4+ T cells

0.41 ± 0.34

0.77 ± 0.76

0.78 ± 0.76

0.79 ± 1.09

0.70 ± 0.42

CD32+ in CD4+ T cells

1.06 ± 0.62

2.85 ± 3.72 a

1.68 ± 1.05

5.97 ± 7.40 a, b

2.86 ± 1.65

CD35+ in CD4+ T cells

5.34 ± 4.74

8.73 ± 8.85

8.33 ± 5.33

5.52 ± 2.15

12.36 ± 16.01

CD21+ in CD8+ T cells

1.16 ± 0.99

2.71 ± 1.86 a

2.07 ± 0.66

4.08 ± 3.33 a

2.92 ± 1.35

CD32+ in CD8+ T cells

3.05 ± 2.52

3.22 ± 3.03

1.88 ± 1.82

2.98 ± 1.95

6.29 ± 3.87 b, c

CD35+ in CD8+ T cells

4.43 ± 1.95

5.43 ± 3.38

5.65 ± 4.48

5.26 ± 1.80

5.23 ± 2.48

CD21+ in CD19+ B cells

84.76 ± 9.66

87.51 ± 6.67

88.13 ± 6.69

86.07 ± 8.20

87.05 ± 5.37

CD32+ in CD19+ B cells

70.02 ± 13.77

66.46 ± 15.42

63.39 ± 16.65

65.90 ± 14.42

74.41 ± 11.67

CD35+ in CD19+ B cells

94.43 ± 4.90

92.63 ± 5.06

93.61 ± 4.58

92.27 ± 1.97

90.57 ± 7.55

  1. Data are presented as mean percentage ± SD.
  2. aP < 0.05 compared to control subjects.
  3. bP < 0.05 compared to RRMS.
  4. cP = 0.051 compared to control subjects.